| Financial Year |
March 31 2023 |
| Monetary Funds |
812,725,588.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
446,629,787.90 |
| Accounts Receivable |
1,566,753,096.03 |
| Advances to Suppliers |
117,680,147.63 |
| Other Receivables |
56,810,661.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,828,722,769.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
147,714,057.58 |
| Total Current Assets |
5,067,677,599.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,681,862.50 |
| Long-term Equity Investment |
-- |
| Investment Properties |
35,695,410.78 |
| Fixed Assetes |
1,385,452,788.72 |
| Under-construction Projects |
209,103,592.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
201,211,810.11 |
| R&D expenses |
139,778,796.66 |
| Goodwill |
363,513,190.73 |
| Long-Term Deferred and Prepaid Expenses |
17,772,258.23 |
| Deferred Income Tax Assets |
174,649,478.01 |
| Other Non-Current Assets |
256,936,518.10 |
| Sub-Total of Non-Current Assets |
3,516,491,038.87 |
| Total Assets |
8,584,168,637.89 |
| Short-Term Loans |
199,942,363.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
440,006,387.95 |
| Accounts Payable |
1,238,131,160.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
174,959,384.25 |
| Taxes Payable |
20,349,184.86 |
| Interest Payable |
-- |
| Dividend Payable |
580,538.89 |
| Other payables |
63,221,903.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
154,694,860.26 |
| Other Current Liabilities |
20,658,970.88 |
| Sub-Total of Current Liabilities |
2,504,860,657.33 |
| Long-term Loans |
473,448,230.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
176,209,050.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,230,328.52 |
| Deferred Income Tax Liabilities |
163,938,653.33 |
| Other Non-Current Liabilities |
93,604,753.96 |
| Sub-Total of Non-Current Liabilities |
1,592,585,579.75 |
| Total Liabilities |
4,097,446,237.08 |
| Paid-In Capital(Or Share Stock) |
798,201,406.00 |
| Capital Surplus |
3,057,012,937.01 |
| Surplus Reserve |
57,838,073.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
324,687,571.17 |
| Minority Stockholder's Interest |
216,551,233.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,270,171,166.88 |
| Owner's Equity（Stockholder's Equity） |
4,486,722,400.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,584,168,637.89 |
